2023年

  1. Tanaka Y, Ota R, Hirata A, Yokoyama S*, Nakagawa C, Uno T, Hosomi K. Effect of baseline urinary glucose levels on the relationship between sodium-glucose cotransporter 2 inhibitors and serum uric acid in Japanese patients with type 2 diabetes mellitus. Pharmazie. 2023 Dec 4;78(11):238-244.
  2. Yokoyama S*, Nakagawa C, Hosomi K. Association between statin use and open-angle glaucoma: A nested case–control study using the Japanese claims database. Sci Rep. 2023 Jul 19;13(1):11677.
  3. Tanaka Y, Yokoyama S*, Nakagawa C, Uno T, Hosomi K. Association between sodium-glucose cotransporter 2 inhibitors and pancreatic cancer in the Japanese working age population. Int J Clin Pharmacol Ther. 2023 Nov;61(11):492-502.
  4. Uno T*, Hosomi K, Yokoyama S, Kawabata K. Trends in tolvaptan prescription and the association between hypernatremia and aging in tolvaptan-treated patients in Japan: Real-world data mining using Japanese databases. Int J Clin Pharmacol Ther. 2023 Jan;61(1):33-36.
  5. 横山聡*，細見光一．レセプトデータベースを中心としたビッグデータの利活用．Yakugaku Zasshi. 2023;143(6)497-500.
  6. Komatsu Y, Yodoshi M, Takegami M, Yokoyama S, Hosomi K*. Association between hemorrhage and direct oral anticoagulants in combination with verapamil: analysis of Japanese Adverse Drug Event Report database and electronic medical record data. Int J Clin Pharmacol Ther. 2023 Apr;61(4):148-158.
  7. Uno T*, Hosomi K, Yokoyama S, Kawabata K. Trends in tolvaptan prescription and the association between hypernatremia and aging in tolvaptan-treated patients in Japan: Real-world data mining using Japanese databases. Int J Clin Pharmacol Ther. 2023 Jan;61(1)33-36.
  8. Nakagawa C, Yokoyama S*, Hosomi K. Association of statin adherence with the development of nonalcoholic fatty liver disease: A nested case-control study using a Japanese claims database. Ann Pharmacother. 2023 Jun;57(6):637-645.

2022年

  1. Yokoyama S*, Nakagawa C, Hosomi K. Treatment strategy of oxaliplatin-induced peripheral neuropathy: A retrospective, nationwide study. Support Care Cancer. 2022; 30(2):1765-1773.
  2. 家田正子, 宮本朋佳, 細見光一, 竹上 学, 川畑篤史. 薬学部生における一般名と商品名による医薬品認識に及ぼす実務実習の影響. 薬局薬学 2022;14:15-25.
  3. Komatsu Y, Yokoyama S, Hosomi K*, Takada M. Impact of Medication Adherence on the Association Between Oral Anticoagulant Use and Risk of Dementia: A Retrospective Cohort Study using the Japanese Claims Database. Drugs Real World Outcomes. 2022 Sep;9(3):437-449.
  4. Uno T*, Takada M, Yokoyama S, Kawabata K, Hosomi K. Effect of mammalian target of rapamycin inhibitors on the cancer risk in patients receiving calcineurin inhibitors: data mining of a spontaneous reporting database. Int J Clin Pharmacol Ther. 2022 Nov;60(11):477-485.
  5. Uno T*, Sakakura K, Mukai Y, Takada M, Noda T, Kusano K, Hayakawa N. Pharmacokinetics and pharmacodynamics of amiodarone in patients with hypertriglyceridemia: Two case reports. Int J Clin Pharmacol Ther. 2022 Dec;60(12):515-520.
  6. Ieda S, Miyamoto T, Hosomi K, Takegami M, Kawabata A*. Identification of Remaining Life Expectancy Less Than Two Weeks by C-Reactive Protein/Albumin Ratio, Prognostic Nutritional Index, Fibrosis-4 Index, and Albumin-Bilirubin Score in Terminal Cancer Patients. J Palliat Med. 2022 Apr;25(4):570-576.
  7. Yamashiro K, Hosomi K, Yokoyama S, Ogata F, Nakamura T, Kawasaki N*. Adverse event profiles of hypomagnesemia caused by proton pump inhibitors using the Japanese Adverse Drug Event Report (JADER) Database.Pharmazie. 2022 Sep 1;77(7):243-247.
  8. Yamashiro K, Jouta M, Hosomi K, Yokoyama S, Ozaki Y, Hirata A, Ogata F, Nakamura T, Tanei S, Kawasaki N*. Adverse event profiles of microscopic colitis in the Japanese Adverse Drug Event Report (JADER) database. Sci Rep. 2022 Oct 21;12(1):17652. doi: 10.1038/s41598-022-22257-2.

2021年

  1. Nakagawa C, Yokoyama S*, Hosomi K, Takada M. Repurposing haloperidol for the treatment of rheumatoid arthritis: An integrative approach using data mining techniques. Ther Adv Musculoskelet Dis. 2021; 13, 1-23. DOI: 10.1177/1759720X211047057
  2. Yokoyama S*, Tanaka Y, Hosomi K, Takada M. Polypharmacy is associated with amiodarone-induced hypothyroidism. Int J Med Sci 2021; 18(15):3574-3580.
  3. Matsui K, Mukai Y, Sakakura K, Wada K, Nakamura T, Kawabata A, Terakawa N, Hayakawa N, Kusano K, Hosomi K, Yokoyama S, Takada M*. Relationship Between Serum Bepridil Concentration and Corrected QT Interval. Int J Clin Pharmacol Ther. 2021 Jan;59(1):63-70.
  4. Mabuchi T, Hosomi K, Yokoyama S, Takada M*. Relationship between polypharmacy and adverse events. Int J Clin Pharmacol Ther. 2021 May;59(5):353-357.
  5. Ieda S, Miyamoto T, Hosomi K, Takegami M, Kawabata A. Identification of Remaining Life Expectancy Less Than Two Weeks by C-Reactive Protein/Albumin Ratio, Prognostic Nutritional Index, Fibrosis-4 Index, and Albumin-Bilirubin Score in Terminal Cancer Patients. J Palliat Med. doi: 10.1089/jpm.2021.0243.

2020年

  1. Mabuchi T, Hosomi K, Yokoyama S, Takada M*. Polypharmacy in three different spontaneous adverse drug event databases. Int J Clin Pharmacol Ther. 2020 Nov;58(11)601-607.
  2. Inose R, Hashimoto N, Hosomi K, Yokoyama S, Takada M*. Association between malignancy and methotrexate and biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis. Int J Clin Pharmacol Ther. 2020 Mar;58(3):131-138.
  3. Yokoyama S*, Wakamoto S, Tanaka Y, Nakagawa C, Hosomi K, Takada M. Association Between Antipsychotics and Osteoporosis Based on Real-World Data. Ann Pharmacother. 2020; 54: 988-995.
  4. Ota R, Hirata A, Noto K, Yokoyama S, Hosomi K, Takada M*, Matsuoka H. Relationship between serum calcium and creatinine in hematopoietic stem cell transplantation patients treated with foscarnet. Int J Clin Pharmacol Ther. 2020; 58(5): 274-281.
  5. Yokoyama S*, Ieda S, Nagano M, Nakagawa C, Iwase M, Hosomi K, Takada M. Association between oral anticoagulants and osteoporosis: Real-world data mining using a multi-methodological approach. Int J Med Sci, 2020; 17(4): 471-479.
  6. Mabuchi T, Hosomi K, Yokoyama S, Takada M*. Polypharmacy in elderly patients in Japan: Analysis of Japanese real-world databases. J Clin Pharm Ther. 2020 Oct;45(5):991-996.
  7. Uno T, Wada K, Hosomi K, Matsuda S, Ikura MM, Takenaka H, Terakawa N, Oita A, Yokoyama S, Kawase A, Takada M*. Drug interactions between tacrolimus and clotrimazole troche: a data mining approach followed by a pharmacokinetic study. Eur J Clin Pharmacol. 2020 Jan;76(1)117-125.
  8. Kinoshita S, Hosomi K, Yokoyama S, Takada M*. Inverse Association between Metformin and Amiodarone-Associated Extracardiac Adverse Events. Int J Med Sci. 2020; 17(3): 302-309.
  9. Kinoshita S, Hosomi K, Yokoyama S, Takada M*. Time-to-onset analysis for amiodarone-induced thyroid dysfunction. J Clin Pharm Ther. 2020 Feb;45(1):65-71.
  10. Iwasawa M, Sagami K, Yokoyama S, Hosomi K, Takada M*. Influence of co-initiation of antiulcer drugs on persistence and adherence to low dose aspirin: A retrospective cohort study using a Japanese claims database. Int J Clin Pharmacol Ther. 2020 Apr;58(4)214-222.

2019年

  1. Yokoyama S*, Sugimoto Y, Nakagawa C, Hosomi K, Takada M. Integrative analysis of clinical and bioinformatics databases to identify anticancer properties of digoxin. Sci Rep. 2019 Nov 12;9(1)16597.
  2. 髙田充隆，【総説】医療ビッグデータを用いた医療薬学研究の現状と展望，薬局薬学，11: 105-113，2019.
  3. Matsui K, Tsubota M, Fukushi S, Koike N, Masuda H, Kasanami Y, Miyazaki T, Sekiguchi F, Ohkubo T, Yoshida S, Mukai Y, Oita A, Takada M, Kawabata A*. Genetic deletion of Cav3.2 T-type calcium channels abolishes H2S-dependent somatic and visceral pain signaling in C57BL/6 mice. J Pharmacol Sci, 140 (3): 310-312, 2019.
  4. Ota R, Hirata A, Noto K, Yokoyama S, Hosomi K, Takada M*. Relationship between the blood concentrations of tacrolimus and voriconazole in hematopoietic stem cell transplant recipients. Int J Clin Pharmacol Ther. 2019 Nov;57(11):561-566.
  5. Yokoyama S*, Hiramoto K, Yamate Y.Impaired skin barrier function caused by reactive oxygen species in mice with colonic tumors. Cutan Ocul Toxicol. 2019, 38(4);349-355.
  6. Yamashita S, Iguchi K, Noguchi Y, Sakai C, Yokoyama S, Ino Y, Hayashi T, Teramachi H, Sako M, Sugiyama T*. Color change in Perlodel® tablets induced by LED lighting – photolysis of bromocriptine mesylate. Pharmazie, 74: 286-289, 2019.
  7. Uno T, Wada K, Matsuda S, Ikura M, Takenaka H, Terakawa N, Oita A, Yokoyama S, Kawase A, Hosomi K, Takada M*. Clotrimazole troches can alter everolimus pharmacokinetics in post-transplant patients: A case report. Br J Clin Pharmacol. 2019 Sep;85(9):2176-2178.
  8. Koizumi Y, Ishiwata S, Inoue T, Takada M, Kawabata A, Kotake T*, Investigation of the levels of ifosfamide vaporized from powder and solution, JJOMT, 67: 95-99, 2019.
  9. Uno T, Wada K, Matsuda S, Terada Y, Oita A, Takada M, Yanase M, Fukushima N, Comparison of CYP3A5*3 genotyping assays for personalizing immunosuppressive therapy in heart transplant patients, Int J Clin Pharmacol Ther, 57: 315-322, 2019.
  10. Iwasawa M, Sagami K, Yokoyama S, Hosomi K, Takada M*, Adherence to the guidelines for antiulcer drug prescription in patients receiving low-dose aspirin therapy in Japan, Int J Clin Pharmacol Ther, 57: 197-206, 2019.
  11. Hirata A, Noto K, Ota R, Yokoyama S, Hosomi K, Takada M*, Matsuoka H, Voriconazole trough concentration and hepatotoxicity in patients with low serum albumin, Int J Clin Pharmacol Ther, 57: 135-143, 2019.
  12. Inose R, Hosomi K, Takahashi K, Yokoyama S, Takada M*, Risk of malignant lymphoma in patients with rheumatoid arthritis treated with biological disease-modifying antirheumatic drugs and methotrexate, Int J Clin Pharmacol Ther, 57: 63-72, 2019.
  13. Uno T, Wada K, Matsuda S, Terada Y, Terakawa N, Oita A, Yokoyama S, Kawase A, Hosomi K, Takada M*, Effects of clotrimazole on tacrolimus pharmacokinetics in patients with heart transplants with different CYP3A5 genotypes, Eur J Clin Pharmacol, 75:67-75, 2019.
  14. 近藤有，江尻将之，間瀬広樹，宮崎雅之，荒川裕貴，築山郁人，佐藤由美子，大島有美子，小山佐知子，牛膓沙織，横山聡，町支優和，佐々木英雄，壁谷めぐみ，久田達也，板倉由縁. 悪性リンパ腫患者に対するCHOP療法に伴う悪心・嘔吐におけるアプレピタントの有用性に関する検討, 日本病院薬剤師会雑誌，55: 279-285, 2019.
  15. 片山広美，三島江津子，佐々木俊則，伴晶子，横山聡，桂川健司，高取裕司，宮崎雅之，佐藤由美子，築山郁人，久田達也，板倉由縁. CapeOX療法の完遂率に影響を与える要因の調査および適切な介入方法を目指した多施設共同研究, 日本病院薬剤師会雑誌, 55: 47-52, 2019

2018年

  1. Yokoyama S*, Tanaka Y, Nakagita K, Hosomi K, Takada M: Bleeding risk of warfarin and direct oral anticoagulants in younger population: a historical cohort study using a Japanese claims database, Int J Med Sci, 15:1686-1693, 2018.
  2. Hosomi K, Fujimoto M, Ushio K, Mao L, Kato J, Takada M*: An integrative approach using real-world data to identify alternative therapeutic uses of existing drugs, PLoS ONE 13(10): e0204648.
  3. Nakagita K, Wada K, Mukai Y, Uno T, Nishino R, Matsuda S, Takenaka H, Terakawa N, Oita A, Takada M*, Effects of vitamin K epoxide reductase complex 1 gene polymorphisms on warfarin control in Japanese patients with left ventricular assist devices (LVAD), Eur J Clin Pharmaco, 74:885-894, 2018.
  4. Uno T, Wada K, Matsuda S, Terada Y, Oita A, Kawase A, Takada M, Impact of the CYP3A51 allele on the pharmacokinetics of tacrolimus in Japanese heart transplant patients, Eur J Drug Metab Pharmacoknet, 43:665-673, 2018.
  5. Nakagita K, Wada K, Terada Y, Matsuda S, Terakawa N, Oita A, Takada M*, The Effect of Fluconazole on the Pharmacokinetics of Everolimus and Tacrolimus in a Heart Transplant Recipient: A Case Report, Int J Clin Pharmacol Ther, 56:270-276, 2018.
  6. Takayoshi M, Wada K, Terada Y, Matsuda S, Nakagita K, Oita A, Takada M, Shionoiri A, Sunami H, Nakajima S, Kuroda K, Sato T, Seguchi O, Yanase M, Fukushima N, Use of rifabutin to treat tuberculosis in a cardiac transplant recipient: A case report, Int J Clin Pharmacol Ther, 56, 184-188, 2018.
  7. Iwasawa M, Wada K, Takada M*: Gastrointestinal risk factors and prescribing pattern of antiulcer agents in patients taking low-dose aspirin in Japan, Int J Pharm Pract, 26:369-372, 2018.
  8. Yamato M, Wada K, Hayashi T, Fujimoto M, Hosomi K, Oita A, Takada M*: Association between serum amiodarone and N-desethylamiodarone concentrations and development of thyroid dysfunction, Clin Drug Invest, 38: 39-48, 2018.
  9. Yokoyama S*, Yajima S, Shimauchi A, Sakai C, Yamashita S, Noguchi Y, Ino Y, Iguchi K, Teramachi H. Oncology pharmacist contributions to treatment with oral anticancer agents in a Japanese community pharmacy setting. Can Pharm J (Ott), 151: 377-382, 2018.
  10. Yokoyama S*, Tamaru S, Tamaki S, Nakanishi D, Mori A, Yamakawa T, Ao T, Sakata Y, Mizuno T, Iwamoto T, Watanabe K, Simomura M, Kawakami K, Konishi N, Kageyama S, Ohtani S, Yamada T, Ban S, Ooi K. Genetic Risk Factors Associated With Antiemetic Efficacy of Palonosetron, Aprepitant, and Dexamethasone in Japanese Breast Cancer Patients Treated With Anthracycline-based Chemotherapy. Clin Breast Cancer, 18: e157-e165, 2018
  11. Yamashita S, Iguchi K, Noguchi Y, Sakai C, Yokoyama S, Ino Y, Hayashi H, Teramachi H, Sako M, Sugiyama T*. Changes in the quality of medicines during storage under LED lighting and consideration of countermeasures. J Pharm Health Care Sci, 4:12, 2018.
  12. Hiramoto K, Orita K, Yamate Y, Kasahara E, Yokoyama S, Sato EF. The Clock Genes Are Involved in The Deterioration of Atopic Dermatitis after Day-and-Night Reversed Physical Stress in NC/Nga Mice. Open Biochem J, 12: 87-102, 2018.
  13. Hiramoto K, Yamate Y, Yokoyama S. Ultraviolet A Eye Irradiation Ameliorates Atopic Dermatitis via p53 and Clock Gene Proteins in NC/Nga Mice. Photochem Photobiol, 94: 378-383, 2018.
  14. Hiramoto K, Yamate Y, Yokoyama S. Ultraviolet B eye irradiation aggravates atopic dermatitis via adrenocorticotropic hormone and NLRP3 inflammasome in NC/Nga mice. Photodermatol Photoimmunol Photomed, 34: 200-210, 2018.
  15. 舘知也，野口義紘，水井貴詞，山下修司，堺千紘，横山聡，伊野陽子，井口和弘，福田聖啓，安田昌宏，後藤千寿，寺町ひとみ. 改訂薬学教育モデル・コアカリキュラムにおける実務実習に向けた大学・施設間の情報共有の実施と薬剤師の意識調査, 医療薬学, 44: 251-259, 2018.
  16. 島内あかり, 長沼美紗, 笹岡沙也加, 畠平春奈, 元岡佑美, 長谷川栞, 福田昌穂, 中尾智史, 堺千紘, 横山聡, 伊野陽子, 中村光浩, 井口和弘. OTC医薬品における添付文書記載状況調査, 薬学雑誌, 138: 259-267, 2018.
  17. 矢島聖子，島内あかり，堺千紘，横山聡，伊野陽子，松永俊之，寺町ひとみ，中村光浩，井口和弘. 政府統計データを用いた薬局に従事する薬剤師の分布に関する調査, 薬学雑誌，138: 991-1000, 2018.
  18. 堺千紘，横山聡，伊野陽子，山下修司，野口義紘，井口和弘，寺町ひとみ. 薬局におけるプレアボイド事例の分析, 薬局薬学，10: 201-207, 2018.